Olympus Corp. (7733)

Currency in JPY
2,110.5
+43.0(+2.08%)
Closed·
Advertisement
7733 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
2,047.02,119.5
52 wk Range
1,302.52,168.0
Key Statistics
Bid/Ask
2,110.00 / 2,115.00
Prev. Close
2,067.5
Open
2,080.5
Day's Range
2,047-2,119.5
52 wk Range
1,302.5-2,168
Volume
5.69M
Average Volume (3m)
4.87M
1-Year Change
21.4676%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
7733 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
2,011.5
Downside
-4.69%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 6 consecutive years

Olympus Corp. News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Analyst Ratings

5 Buy
8 Hold
1 Sell
Ratings:
14 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 2,011.5
(-4.69% Downside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
Citi
Buy2,500.00+18.46%2,200.00Maintain14/08/2026
Goldman Sachs
Hold2,300.00+8.98%2,050.00Maintain10/08/2026
JPMorgan
Buy1,900.00-9.97%1,700.00Maintain22/06/2026
Goldman Sachs
Hold2,050.00-2.87%-Downgrade16/06/2026
Citi
Buy2,200.00+4.24%2,300.00Maintain02/06/2026

Olympus Corp. Earnings Call Summary for Q1/2027

  • Olympus reported strong Q1 fiscal 2027 results exceeding analyst forecasts; shares rose 1.82% to $1,906, with GIS operating margin reaching 23.3%.
  • Company maintained full-year guidance unchanged despite Q1 beat, citing offsetting factors including North America strength and China's 17.3% revenue decline.
  • Restructuring efforts yielded JPY 200 billion in expected fiscal 2027 savings, with SG&A expenses down 5.5% on constant currency basis after 2,000 headcount cuts.
  • Management faces ongoing challenges including unresolved FDA warning letter, JPY 13 billion ship-hold impact in Q1, and persistent China market weakness.
  • Executives expect continued GIS strength from EVIS X1 adoption and second-half recovery from ship-hold disruptions, with full run-rate savings of JPY 260 billion by 2028.
Last Updated: 07/08/2026, 16:24
Read Full Transcript

Earnings

Latest Release
07/08/2026
EPS / Forecast
17.76 / 9.40
Revenue / Forecast
240.4B / 225.91B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 71.10%
Dividend Yield
1.45%
Industry Median 1.66%
Annualised payout
30.00
Paid unevenly
5-Years Growth
+20.11%
Growth Streak

Compare 7733 to Peers and Sector

Metrics to compare
7733
Peers
Sector
Relationship
P/E Ratio
28.7x18.5x−0.4x
PEG Ratio
−1.020.650.00
Price/Book
3.0x1.7x2.6x
Price / LTM Sales
2.1x1.5x3.1x
Upside (Analyst Target)
−9.5%19.5%47.8%
Fair Value Upside
Unlock11.2%6.2%Unlock

Olympus Corporation, together with its subsidiaries, engages in the manufacture and sale of medical equipment in Japan, America, the Middle East, Asia, and Oceania. It operates through two segments, “Gastrointestinal Solutions and Surgical & Interventional Solutions. The company offers gastrointestinal Solutions products offer gastrointestinal endoscopes, gastroenterology devices, and medical services. The Surgical & Interventional Solutions provides urology, respiratory, surgical endoscopes, energy devices, ENT products, and gynecology products. It also provides respiratory products comprising bronchoscopy systems and devices, lung cancer products, and chronic obstructive pulmonary disease products; urology products consisting of visualization, stone management, benign prostatic hyperplasia (BPH), and BPH + bladder cancer products; surgical products, such as surgical endoscopy systems, advanced energy devices, surgical microscope, integrated procedure room solutions, and rhino-laryngoscopy systems, as well as surgical devices for the ears, nose, and throat. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was incorporated in 1919 and is headquartered in Hachioji, Japan.

Employees
28138
Market
Japan

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
459.62M43.27%970.02B
Other Institutional Investors
207.98M19.59%438.94B
Public Companies & Retail Investors
394.56M37.15%832.72B
Total
1.06B100.00%2.24T

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Nomura Asset Management Co., Ltd.7.41%78,702,500166,101,626
Artisan Partners Limited Partnership5.90%62,706,900132,342,912

People Also Watch

6,471.0
9104
+3.06%
9,585.0
5713
-2.42%
6,376.0
8591
+0.06%
1,291.0
5020
+0.66%
943.00
300308
+2.38%

FAQ

What Is the Olympus Corp. (Tokyo: 7733) Share Price Today?

The Olympus Corp. stock price today is 2,110.5 JPY.

What Stock Exchange Does Olympus Corp. (7733) Trade On?

Olympus Corp. is listed and trades on the Tokyo Stock Exchange.

What Is the Ticker (Stock Symbol) for Olympus Corp.?

The stock symbol (also called a 'ticker') for Olympus Corp. is "7733."

Does Olympus Corp. Pay Dividends? What’s The Current 7733 Dividend Yield?

Yes, 7733 Pays Dividends to its Shareholders. The current Olympus Corp. dividend yield is 1.45%.

What Is the Current Olympus Corp. Market Capitalisation?

As of today, Olympus Corp. (Tokyo: 7733) market cap is 2.24T JPY.

What Is Olympus Corp.'s (7733) Earnings Per Share (TTM)?

The Olympus Corp. EPS is currently 71.1 (Trailing Twelve Months).

When Is the Next Olympus Corp. Earnings Date?

Olympus Corp.'s next earnings report will be released on 06/11/2026.

Is 7733 a Buy or Sell From a Technical Analyst Perspective?

Based on today's Olympus Corp. moving averages and other technical indicators, the daily buy/sell signal for 7733 stock is Strong Buy.

How Many Times Has Olympus Corp. Stock Split?

Olympus Corp. has split 1 times. (See the 7733 stock split history page for full effective split date and price information.)

How Many Employees Does Olympus Corp. Have?

Olympus Corp. has 28138 employees, based on their latest Companies House report.

What is the current trading status of Olympus Corp. (Tokyo: 7733)?

As of 15/08/2026, Olympus Corp. (7733) is trading at a share price of 2,110.5 JPY, with a previous close of 2,067.5 JPY. The stock has fluctuated within a day range of 2,047.0 JPY to 2,119.5 JPY, while its 52-week range spans from 1,302.5 JPY to 2,168.0 JPY.

What Is Olympus Corp. (7733) Price Target According to Analysts?

The average 12-month price target for Olympus Corp. is 2,011.5 JPY, with a high estimate of 2500 JPY and a low estimate of 1600 JPY. 5 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Neutral. The stock has an -4.69% Downside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.